Aarkstore - Post-Operative Pain - Pipeline Review, H2 2014

1. Pharmaceutical and Healthcare Market Research Report Post-Operative Pain - Pipeline Review, H2 2014 For More Information Visit : www.aarkstore.com

2. Summary ‘Post-Operative Pain - Pipeline Review, H2 2014’, provides an overview of the Post-Operative Pain’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Post-Operative Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Post-Operative Pain and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information.  For More Information Visit : www.aarkstore.com

3. Scope - The report provides a snapshot of the global therapeutic landscape of Post-Operative Pain- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Post-Operative Pain and enlists all their major and minor projects- The report summarizes all the dormant and discontinued pipeline projects - A review of the Post-Operative Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages- A detailed assessment of monotherapy and combination therapy pipeline projects- Coverage of the Post-Operative Pain pipeline on the basis of target, MoA, route of administration and molecule type- Latest news and deals relating related to pipeline products For More Information Visit : www.aarkstore.com

4. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Develop strategic initiatives by understanding the focus areas of leading companies- Identify and understand important and diverse types of therapeutics under development for Post-Operative Pain- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline- Devise corrective measures for pipeline projects by understanding Post-Operative Pain pipeline depth and focus of Indication therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline For More Information Visit : www.aarkstore.com

5. Table of Content Introduction 10Global Markets Direct Report Coverage 10Post-Operative Pain Overview 11Therapeutics Development 12Pipeline Products for Post-Operative Pain - Overview 12Pipeline Products for Post-Operative Pain - Comparative Analysis 13Post-Operative Pain - Therapeutics under Development by Companies 14Post-Operative Pain - Pipeline Products Glance 17Late Stage Products 17Clinical Stage Products 18Early Stage Products 19Post-Operative Pain - Products under Development by Companies 20Post-Operative Pain - Companies Involved in Therapeutics Development 23A. MenariniIndustrieFarmaceuticheRiuniteSrl 23AcelRx Pharmaceuticals, Inc. 24 For More Information Visit : www.aarkstore.com

6. List of Tables Number of Products under Development for Post-Operative Pain, H2 2014 12Number of Products under Development for Post-Operative Pain - Comparative Analysis, H2 2014 13Number of Products under Development by Companies, H2 2014 15Number of Products under Development by Companies, H2 2014 (Contd..1) 16Comparative Analysis by Late Stage Development, H2 2014 17Comparative Analysis by Clinical Stage Development, H2 2014 18Comparative Analysis by Early Stage Development, H2 2014 19Products under Development by Companies, H2 2014 20Products under Development by Companies, H2 2014 (Contd..1) 21Products under Development by Companies, H2 2014 (Contd..2) 22Post-Operative Pain - Pipeline by A. MenariniIndustrieFarmaceuticheRiuniteSrl, H2 2014 23Post-Operative Pain - Pipeline by AcelRx Pharmaceuticals, Inc., H2 2014 24Post-Operative Pain - Pipeline by Adynxx, Inc., H2 2014 25Post-Operative Pain - Pipeline by AngioChem Inc., H2 2014 26Post-Operative Pain - Pipeline by Aoxing Pharmaceutical Company, Inc, H2 2014 27Post-Operative Pain - Pipeline by BoehringerIngelheim GmbH, H2 2014 28 For More Information Visit : www.aarkstore.com

7. List of Figures Number of Products under Development for Post-Operative Pain, H2 2014 12Number of Products under Development for Post-Operative Pain - Comparative Analysis, H2 2014 13Number of Products under Development by Companies, H2 2014 14Comparative Analysis by Late Stage Development, H2 2014 17Comparative Analysis by Clinical Stage Development, H2 2014 18Comparative Analysis by Early Stage Products, H2 2014 19Assessment by Monotherapy Products, H2 2014 55Assessment by Combination Products, H2 2014 56Number of Products by Top 10 Targets, H2 2014 57Number of Products by Stage and Top 10 Targets, H2 2014 57Number of Products by Top 10 Mechanism of Actions, H2 2014 59Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 59Number of Products by Top 10 Routes of Administration, H2 2014 61Number of Products by Stage and Top 10 Routes of Administration, H2 2014 62Number of Products by Top 10 Molecule Types, H2 2014 63 For More Information Visit : www.aarkstore.com

8. Related Reports Fabry Disease-Pipeline Insights, 2015 Ocular Hypertension-Pipeline Insights, 2015 Fallopian Tube Cancer-Pipeline Insights, 2015 Ocular Inflammation-Pipeline Insights, 2015 Familial AdenomatousPolyposis Coli-Pipeline Insights, 2015 Ocular Pain-Pipeline Insights, 2015 Oligodendroglioma-Pipeline Insights, 2015 Familial Chylomicronemia (Type I Hyperlipoproteinemia)-Pipeline Insights, 2015 For More Information Visit : www.aarkstore.com

9. Follow Us https://www.facebook.com/aarkstoredotcom https://twitter.com/aarkstore https://plus.google.com/+Aarkstoredotcom/posts https://www.linkedin.com/company/aarkstore-enterprise For More Information Visit : www.aarkstore.com

10. Contact Us Office Address Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Mail us at contact@aarkstore.com 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 For More Information Visit : www.aarkstore.com